The role of hyperhomocysteinemia (HHcy) as a risk marker for cardiovascular diseases in renal patients is a matter of controversy...
Keywords: homocysteine, methylmalonic acid, renal patients, vitamin B12
10/2005 | Clinical Chemical Laboratory Medicine, Walter de Gruyter